241 related articles for article (PubMed ID: 7930610)
1. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
Valensi JP; Carlson JR; Van Nest GA
J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
[TBL] [Abstract][Full Text] [Related]
2. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
3. Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice.
Wu J; Wang F; Fang F; Zhang W; Chang H; Zheng L; Chen Z
Arch Virol; 2011 Mar; 156(3):387-95. PubMed ID: 21110049
[TBL] [Abstract][Full Text] [Related]
4. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
Caproni E; Tritto E; Cortese M; Muzzi A; Mosca F; Monaci E; Baudner B; Seubert A; De Gregorio E
J Immunol; 2012 Apr; 188(7):3088-98. PubMed ID: 22351935
[TBL] [Abstract][Full Text] [Related]
5. MF-59 adjuvant influence on the functions of gammadelta T cells in HIV-1+ adults immunized with influenza seasonal vaccine.
Fenoglio D; Zocchi MR; Parodi A; Durando P; Gabutitp G; Gasparini R; Poggi A
J Prev Med Hyg; 2011 Sep; 52(3):137-41. PubMed ID: 22010544
[TBL] [Abstract][Full Text] [Related]
6. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
Ott G; Barchfeld GL; Van Nest G
Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
[TBL] [Abstract][Full Text] [Related]
8. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
Vesikari T; Groth N; Karvonen A; Borkowski A; Pellegrini M
Vaccine; 2009 Oct; 27(45):6291-5. PubMed ID: 19840662
[TBL] [Abstract][Full Text] [Related]
9. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
[TBL] [Abstract][Full Text] [Related]
10. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
11. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
[TBL] [Abstract][Full Text] [Related]
12. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.
de Bruijn I; Meyer I; Gerez L; Nauta J; Giezeman K; Palache B
Vaccine; 2007 Dec; 26(1):119-27. PubMed ID: 18063446
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells internalize vaccine adjuvant after intramuscular injection.
Dupuis M; Murphy TJ; Higgins D; Ugozzoli M; van Nest G; Ott G; McDonald DM
Cell Immunol; 1998 May; 186(1):18-27. PubMed ID: 9637761
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
15. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
16. MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.
Podda A; Del Giudice G
Expert Rev Vaccines; 2003 Apr; 2(2):197-203. PubMed ID: 12899571
[TBL] [Abstract][Full Text] [Related]
17. Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.
Del Giudice G; Fragapane E; Bugarini R; Hora M; Henriksson T; Palla E; O'hagan D; Donnelly J; Rappuoli R; Podda A
Clin Vaccine Immunol; 2006 Sep; 13(9):1010-3. PubMed ID: 16960112
[TBL] [Abstract][Full Text] [Related]
18. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.
Bernstein DI; Edwards KM; Dekker CL; Belshe R; Talbot HK; Graham IL; Noah DL; He F; Hill H
J Infect Dis; 2008 Mar; 197(5):667-75. PubMed ID: 18260764
[TBL] [Abstract][Full Text] [Related]
19. Development of an adjuvant to enhance the immune response to influenza vaccine in the elderly.
Martin JT
Biologicals; 1997 Jun; 25(2):209-13. PubMed ID: 9236054
[TBL] [Abstract][Full Text] [Related]
20. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
Baldwin SL; Shaverdian N; Goto Y; Duthie MS; Raman VS; Evers T; Mompoint F; Vedvick TS; Bertholet S; Coler RN; Reed SG
Vaccine; 2009 Oct; 27(43):5956-63. PubMed ID: 19679214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
